ID
21836
Beschreibung
HD16 NCT Nr.: NCT00736320 HD16 for Early Stages - Treatment Optimization Trial in the First-line Treatment of Early Stage Hodgkin Lymphoma; Treatment Stratification by Means of FDG-PET. This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of Progression free survival (PFS). HD17 NCT Nr.: NCT01356680 HD17 for Intermediate Stages - Treatment Optimization Trial in the First-Line Treatment of Intermediate Stage Hodgkin Lymphoma.This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of progression free survival (PFS). HD18 NCT Nr.: NCT00515554 HD18 for Advanced Stages in Hodgkins Lymphoma. This study is designed to test: in patients with negative positron-emission tomography (PET) after 2 cycles of BEACOPPesc chemotherapy: whether the number of cycles can be reduced without compromising progression free survival (PFS) (2 further cycles vs. 6 further cycles) for patients with positive PET after 2 cycles: whether intensifying BEACOPPesc chemotherapy by adding Rituximab improves PFS. Permission granted by: Andreas Engert, M.D. Chairman, German Hodgkin Study Group Professor for Internal Medicine Hematology & Oncology University Hospital of Cologne Department of Internal Medicine I Kerpener Str. 62 D-50924 Köln Phone: +49-221-478-5933/5966 Fax: +49-221-478-3778 a.engert@uni-koeln.de
Stichworte
Versionen (5)
- 24.04.17 24.04.17 -
- 25.04.17 25.04.17 -
- 03.05.17 03.05.17 -
- 14.11.18 14.11.18 - Sarah Riepenhausen
- 15.03.21 15.03.21 - Dr. rer. medic Philipp Neuhaus
Hochgeladen am
3. Mai 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
German Hodgkin Study Group Study HD16/HD17/HD18 Treatment discontinuation form G6AB DRKS00003455 DRKS00003457
Deutsche Hodgkin Studiengruppe: G6AB Therapieabbruchbogen
- StudyEvent: ODM
Beschreibung
Therapieabbruchbogen
Beschreibung
Date of discontinuation
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0011008
Beschreibung
Reason for discontinuation
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C0457454
Beschreibung
Treatment status
Datentyp
integer
Alias
- UMLS CUI [1]
- C0749659
Beschreibung
Further documentation
Datentyp
text
Alias
- UMLS CUI [1]
- C0175636
Beschreibung
Date of completion
Datentyp
date
Alias
- UMLS CUI [1]
- C0011008
Beschreibung
Signature
Datentyp
text
Alias
- UMLS CUI [1]
- C1519316
Ähnliche Modelle
Deutsche Hodgkin Studiengruppe: G6AB Therapieabbruchbogen
- StudyEvent: ODM
C1515258 (UMLS CUI [1,2])
C1442065 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,2])